ABBV
AbbVie insider trading
Health Care · Heavy selling
Close · Oct 5, 2026
$265.76
+19.0% over 12 months
Share price and insider trades
ABBV closeInsider buyInsider sale
Bought, 12 months$0
Sold, 12 months$18.9M
Insiders buying0
Insiders selling3
Valuation, profit and volume
P/E (trailing)n/aSector median 24.5
Market value—
Profit margin—Revenue growth —
Volume vs. 50-day1.1×Last 5 sessions
Insiders' paper profit—On all tracked purchases —
Summary
Over the past 12 months, 0 AbbVie insiders reported open-market purchases totaling $0, while 3 insiders reported sales totaling $18.9M. 4 of 6 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales. 59 grants, option exercises and tax withholdings are not shown.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Aug 18SEC | Nicholas DonoghoeEvp, Chief Bus/Strat Officer | Sell | 32,710 | $250.00 | $8.2M | +6.3% | — |
| Mar 6SEC | David Ryan PurdueSvp, Controller | Sell | 5,230 | $233.56 | $1.2M | +13.8% | — |
| Mar 3SEC | Perry C SiatisEvp, Gc And Secretary | Sell Plan | 10,291 | $234.66 | $2.4M | +13.3% | — |
| Mar 3SEC | Perry C SiatisEvp, Gc And Secretary | Sell Plan | 5,777 | $233.51 | $1.3M | +13.8% | — |
| Mar 3SEC | Perry C SiatisEvp, Gc And Secretary | Sell Plan | 2,600 | $235.26 | $612K | +13.0% | — |
| Feb 27SEC | Perry C SiatisEvp, Gc And Secretary | Sell Plan | 22,381 | $230.00 | $5.1M | +15.5% | — |
Insiders at AbbVie
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Perry C SiatisEvp, Gc And Secretary | — | $9.5M | Mar 3, 2026 | — |
| Nicholas DonoghoeEvp, Chief Bus/Strat Officer | — | $8.2M | Aug 18, 2026 | — |
| David Ryan PurdueSvp, Controller | — | $1.2M | Mar 11, 2026 | — |
| Roxanne S AustinDirector | — | — | May 12, 2026 | — |
| Edward J RappDirector | — | — | May 12, 2026 | — |
| Thomas J FalkDirector | — | — | May 12, 2026 | — |
| Frederick H WaddellDirector | — | — | May 12, 2026 | — |
| Thomas C FreymanDirector | — | — | May 12, 2026 | — |
| Rebecca B RobertsDirector | — | — | May 12, 2026 | — |
| Brett J HartDirector | — | — | May 12, 2026 | — |
| William H.l. BurnsideDirector | — | — | May 12, 2026 | — |
| Melody B MeyerDirector | — | — | May 12, 2026 | — |
| Jennifer L. DavisDirector | — | — | May 12, 2026 | — |
| Susan E QuagginDirector | — | — | May 12, 2026 | — |
| Demetris D CrumEvp, Chief Hr Officer | — | — | Mar 6, 2026 | — |
| Robert A. MichaelCEO, Chair | — | — | Mar 3, 2026 | — |
| Jeffrey Ryan StewartEvp, Chief Commercial Officer | — | — | Mar 3, 2026 | — |
| Scott T ReentsCFO | — | — | Mar 3, 2026 | — |
| Azita Saleki-gerhardtEvp, Chief Operations Officer | — | — | Mar 3, 2026 | — |
| Roopal ThakkarEvp, R&D And Cso | — | — | Mar 3, 2026 | — |
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
Common questions about ABBV insiders
Are AbbVie insiders buying ABBV stock?
In the past 12 months, 0 insiders reported open-market purchases of ABBV worth $0.
Are AbbVie insiders selling ABBV stock?
3 insiders reported sales worth $18.9M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.